Cytori Cell Research Institute, Inc. (3750.T)
JPY 685.0
(-0.44%)
JPY 685.0
(-0.44%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.56 Billion JPY | -27.24% |
| 2022 | 2.14 Billion JPY | 60.58% |
| 2021 | 1.33 Billion JPY | -3.8% |
| 2020 | 1.38 Billion JPY | 17.65% |
| 2019 | 1.18 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 39 Million JPY | -73.79% |
| 2023 Q2 | 390.05 Million JPY | -17.44% |
| 2023 Q1 | 472.47 Million JPY | -4.14% |
| 2023 Q4 | 148.79 Million JPY | -72.9% |
| 2023 Q3 | 549.05 Million JPY | 40.76% |
| 2023 FY | 1.56 Billion JPY | -27.24% |
| 2022 Q3 | 479.09 Million JPY | -23.86% |
| 2022 FY | 2.14 Billion JPY | 60.58% |
| 2022 Q4 | 492.87 Million JPY | 2.88% |
| 2022 Q2 | 629.2 Million JPY | 0.0% |
| 2021 FY | 1.33 Billion JPY | -3.8% |
| 2020 FY | 1.38 Billion JPY | 17.65% |
| 2019 FY | 1.18 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 67.288% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -1281.779% |
| GNI Group Ltd. | 26.01 Billion JPY | 94.001% |
| Linical Co., Ltd. | 12.3 Billion JPY | 87.322% |
| Trans Genic Inc. | 13.08 Billion JPY | 88.074% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -135.871% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 69.751% |
| AnGes, Inc. | 152.98 Million JPY | -919.961% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -155.752% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 87.777% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | -91.06% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -1051.51% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 4.029% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -264.267% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 17.926% |
| Chiome Bioscience Inc. | 682.46 Million JPY | -128.64% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 35.819% |
| PeptiDream Inc. | 28.71 Billion JPY | 94.565% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -2375.313% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -1189.577% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -2167105.556% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -3812.021% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 65.406% |
| FunPep Company Limited | 530 Thousand JPY | -294312.83% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -2153.268% |
| Stella Pharma Corporation | 269.49 Million JPY | -479.013% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -392.519% |
| Cuorips Inc. | 23.1 Million JPY | -6654.342% |
| K Pharma,Inc. | 1 Billion JPY | -56.039% |
| Takara Bio Inc. | 43.5 Billion JPY | 96.413% |
| ReproCELL Incorporated | 2.42 Billion JPY | 35.702% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 9.032% |
| StemCell Institute Inc. | 2.48 Billion JPY | 37.111% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 37.937% |
| CellSeed Inc. | 190.13 Million JPY | -720.678% |